ADC Therapeutics SA
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES

Last updated:

Abstract:

The present disclosure relates to pyrrolobenzodiazepines (PBDs) having a labile C2 or N10 protecting group in the form of a linker to an antibody.

Status:
Application
Type:

Utility

Filling date:

20 Jul 2021

Issue date:

20 Jan 2022